Diabetes drug linked to osteoporosis 0

GSK’s drug for diabetes Avandia (Rosiglitazone) has come under the scanner after reports that the drug increases the risk of Osteoporosis has been confirmed.

Rosiglitazone belongs to a class of drugs called as Thiazolidinediones (aka PPAR Gamma activators) and the other drug in this class is Pioglitazone. It has been a useful drug in the management of Type II Diabetes and it works by increasing the sensitivity of the body cells to circulating Insulin.